Factors Hindering Human Papillomavirus(HPV) Vaccination Uptake Among Children and Young Adults between Ages Nine to Twenty-Six in America

This Integrative Review Project searched relevant literature and conducted research to discover factors hindering HPV vaccination among children and young adults in America and interventions to increase HPV vaccination among individuals in this group. The importance of the HPV vaccination cannot be understated; the HPV vaccine is the most effective approach for preventing infections and decreasing risk of HPV-associated conditions such as cervical, oral pharyngeal, and rectal cancer. In the United States, HPV inoculation uptake is reported to be less than 80% for the initial dosage, and less than 40% of young males and females complete all the series dosage of the HPV vaccination. The HPV vaccination has been approved since 2006, with many countries undertaking measures and interventions to increase vaccination. HPV vaccination requires multiple shots, offered in either two or three doses; the World Health Organization (WHO) recommends an 80% uptake. The purpose of the project was to searched current literature to find out why HPV vaccination is lower in the United States in comparison to other high-income countries. The search included multiple databases: CINAHL, a conceptual framework that supports methodological rigor, PRISMA data chronology flow chart is used for the processing of the data review. The results show that increasing healthcare providers’ awareness, public education, health literacy awareness, and partnership within the healthcare system can improve HPV vaccination delivery. The project suggests that community awareness that the HPV vaccine is safe and crucial in preventing HPV infection can significantly increase HPV vaccination uptake in the United States